Cohen David E — SEC insider filings
SEC reporting owner CIK 1347383. 9 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2021-05-13 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 6,056 shares, $123,094 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 5,456 shares @ $20.21 ($110,266) in Evommune, Inc., filed 2026-06-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Evommune, Inc. (EVMN) | Director | 4 | — | 2 legs · 6,056 sh · $123,094 | 8 |
| Kadmon Holdings, Inc. (KDMN) | Director | 2 | — | — | 5 |
| Timber Pharmaceuticals, Inc. (TMBR) | Director | 3 | — | — | 5 |
Insider filings — Cohen David E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Evommune, Inc. (EVMN) | Disposition to issuer (D): 37,960 (derivative) · Grant/award (A): 37,960 (derivative) · Disposition to issuer (D): 15,673 (derivative) · Grant/award (A): 15,673 (derivative) | EDGAR |
| 2026-06-03 | 4 | Evommune, Inc. (EVMN) | Sale (S): 5,456 @ $20.21 · Sale (S): 600 @ $21.38 · Grant/award (A): 15,673 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | Evommune, Inc. (EVMN) | Conversion (C): 6,056 · Conversion (C): 51,588 (derivative) | EDGAR |
| 2025-11-07 | 4 | Evommune, Inc. (EVMN) | Grant/award (A): 37,960 (derivative) @ $0 | EDGAR |
| 2023-04-18 | 4 | Timber Pharmaceuticals, Inc. (TMBR) | Grant/award (A): 4,100 @ $0 · Grant/award (A): 4,100 (derivative) @ $0 | EDGAR |
| 2022-04-19 | 4 | Timber Pharmaceuticals, Inc. (TMBR) | Grant/award (A): 100,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-11-09 | 4 | Kadmon Holdings, Inc. (KDMN) | Disposition to issuer (D): 64,935 (derivative) @ $7.23 · Disposition to issuer (D): 100,000 (derivative) @ $7.21 · Disposition to issuer (D): 85,034 (derivative) @ $5.06 · Disposition to issuer (D): 96,975 (derivative) @ $5.92 | EDGAR |
| 2021-07-06 | 4 | Timber Pharmaceuticals, Inc. (TMBR) | Grant/award (A): 71,893 (derivative) @ $0 | EDGAR |
| 2021-05-13 | 4 | Kadmon Holdings, Inc. (KDMN) | Grant/award (A): 96,975 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1347383 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs